Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Sorafenib tosylate
Cat. No.:
OB0125LY-073
Appearance:
Solid
Purity:
99.8%
Identity:
Confirmed by HPLC.
Size:
Add to basket
Product Overview
Description:
Sorafenib tosylate is a potent multikinase inhibitor that inhibits multiple tyrosine kinases, including RAF kinase, VEGFR (vascular endothelial growth factor receptor) and PDGFR (platelet-derived growth factor receptor).
Synonym:
475207-59-1; Bay 43-9006; Nexavar; Nexavar (R); Sorafenib tosilate; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate)
CAS No.:
475207-59-1
Compound CID:
406563
Formula:
C21H16ClF3N4O3·C7H8O3S
Formula Weight:
637.03
Specification
Targets & IC50:
PDGFRβ: 57 nM (cell free); c-Kit: 68 nM (cell free); B-Raf V599E: 38 nM (cell free); Raf-1: 6 nM (cell free0; B-Raf: 22 nM (cell free); VEGFR3: 20 nM (cell free)
Relative Density:
1.454 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Sorafenib tosylate can be used to inhibit tumor cell proliferation and neoangiogenesis.
Library Information
Targets:
c-Kit; Autophagy; PDGFR; Apoptosis; VEGFR; FLT; Raf; Ferroptosis
Receptors:
Apoptosis; Autophagy; B-Raf; B-Raf (V599E); c-Kit; Ferroptosis; FLT3; mPDGFRβ; PDGFRβ; Raf; Raf-1; VEGFR; VEGFR2/Flk1
Pathways:
Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine kinase/adaptors
Plate Number:
AOCL-7
Plate Location:
d5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
200 mg/mL; 313.96 mM
Water Max Solubility:
1 mg/mL
Ethanol Max Solubility:
1 mg/mL
Saline Max Solubility:
5 mg/mL; 7.85 mM
ALogP:
5.824
HBA_Count:
4
HBD_Count:
3
Rotatable Bond:
7
